Peer-reviewedCC BYBiomedicines
Pharmacological Fingerprinting of Cholesterol Biosynthesis Defects
- 1Department of Medical Biology and Getetics, Faculty of Medicine Osijek, J. J. Strossmayer , 31500 Osijek, Croatia (I.Š.); (M.H.)
Related
- m6A-Driven Intratumoral Cholesterol Biosynthesis Fuels Castration-Resistant Prostate Cancer Progression
- VCP-Regulated LMF2 Stabilizes the Cholesterol Biosynthesis Enzyme HMGCS1 to Drive Cancer Progression and Confer Capecitabine Resistance in Triple-Negative Breast Cancer.
- Sex differences in glycine biosynthesis drives sex-specific responses to combined nutrient deprivation and pharmacological inhibition in brain tumors
- Sorting nexin 10 promotes triple-negative breast cancer progression through modulating cholesterol biosynthesis via stabilizing SREBP2.
- Pharmacological Activation of Autophagy Ameliorates Neuromuscular-Associated Defects and Extends Lifespan in a Caenorhabditis elegans Model of Spinal Muscular Atrophy.
BibTeX
@article{fenrich2026pharmacological,
title = {{Pharmacological Fingerprinting of Cholesterol Biosynthesis Defects}},
author = {Matija Fenrich and Ivan Šimunović and Marta Balog and Marija Heffer},
journal = {Biomedicines},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13701852},
note = {CC BY},
}
RIS
TY - JOUR
TI - Pharmacological Fingerprinting of Cholesterol Biosynthesis Defects
AU - Matija Fenrich
AU - Ivan Šimunović
AU - Marta Balog
AU - Marija Heffer
PY - 2026
DA - 2026/10/01
JO - Biomedicines
UR - https://europepmc.org/article/PMC/PMC13701852
SN - 2227-9059
ER -